Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Torben Elhauge"'
Publikováno v:
Journal of Opioid Management. 13:111-124
Objective: To characterize the pharmacokinetics (PK) and in vitro alcohol dissolution characteristics of extended-release (ER), injection-molded (IM) morphine tablets with abuse-deterrent (AD) features (morphine-ADER-IMT). Design: In vivo, in vitro,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e0c4bf6fa76aaa6382ce6d4c325ccf
https://doi.org/10.5055/jom.2017.0375
https://doi.org/10.5055/jom.2017.0375
Publikováno v:
The American Journal of Drug and Alcohol Abuse. 43:291-298
Background: US FDA guidance recommends measuring the degree of effort needed to manipulate abuse-deterrent (AD) opioids. The ALERRT® instrument (PinneyAssociates; Bethesda, MD) uses visual analog scales to assess the labor, effort, and resources nec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0d933af217894ae5930102a0a8325e5
https://doi.org/10.1080/00952990.2016.1278006
https://doi.org/10.1080/00952990.2016.1278006
Autor:
Christopher Altomare, Penny Toren, Sebastian Schwier, Stephen W. Hoag, Karsten Lindhardt, Beatrice Setnik, Robert Bianchi, Torben Elhauge
Publikováno v:
Pain practice : the official journal of World Institute of Pain. 19(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320519407c42722fd1c30ee46a2ad1a6
https://pubmed.ncbi.nlm.nih.gov/31286642
https://pubmed.ncbi.nlm.nih.gov/31286642
Publikováno v:
Journal of opioid management. 13(6)
Objective: A novel technology platform (Guardian ™ Technology, Egalet Corporation, Wayne, PA) was used to manufacture morphine abuse-deterrent (AD), extended-release (ER), injection-molded tablets (morphine-ADER-IMT; ARYMO ® ER [morphine sulfate]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e160b54fdf687d7e55962cfb4d655b
https://pubmed.ncbi.nlm.nih.gov/29308592
https://pubmed.ncbi.nlm.nih.gov/29308592
Publikováno v:
The American journal of drug and alcohol abuse. 43(3)
US FDA guidance recommends measuring the degree of effort needed to manipulate abuse-deterrent (AD) opioids. The ALERRTUse the ALERRTFour technicians tested the products using 10 household tools. The ALERRT instrument quantified effort (all tools) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c7395e722d828843da90b79037816824
https://pubmed.ncbi.nlm.nih.gov/28448223
https://pubmed.ncbi.nlm.nih.gov/28448223
Publikováno v:
PM&R. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64f9d018830c99f29d293c8715871c81
https://doi.org/10.1016/j.pmrj.2016.07.342
https://doi.org/10.1016/j.pmrj.2016.07.342
Publikováno v:
Drug and Alcohol Dependence. 171:e58
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c338df287e59a8725a30f81386e5b39
https://doi.org/10.1016/j.drugalcdep.2016.08.171
https://doi.org/10.1016/j.drugalcdep.2016.08.171